Member Exclusive

Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds

This special report, brought to MedChemNet members by Future Medicinal Chemistry, discusses progress in the development of novel anticancer drugs based on ruthenium(II)- and iron(II)-cyclopentadienyl scaffolds.

1
0

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.

Register

No comments yet.